| Literature DB >> 32064134 |
Hyun-Ji Park1, Chul-Kyu Lee1, Si-Hwan Song1, Jee-Hye Yun2, Ahsa Lee2, Hee-Jung Park3.
Abstract
This study was performed to investigate the effects of highly bioavailable curcumin as Theracurmin® (TC) in rats with monosodium iodoacetate (MIA)-induced osteoarthritis (OA). Seventy-seven male Wistar rats were divided into six groups: normal, negative control (MIA only), positive control (Cerebrex), and three experimental groups treated with 500, 1300, or 2600 mg/kg of TC for 5 weeks. MIA injection-induced OA caused 30% weight-bearing imbalance whereas weight bearing imbalance was significantly improved in the TC groups. Mankin scores revealed TC treatment had significantly ameliorated cartilage damage and chondrocyte decrease. The expressions of nitrotyrosine, tumor necrosis factor-α, phosphorylated nuclear factor kappa B cells, and cleaved caspase-3 were markedly increased in rat with MIA-induced OA, but the TC-treated groups exhibited a significant reduction in the number of immunoreactive cells in a dose-dependent manner. In conclusion, administration of TC contributes to the anti-arthritic effect in rat with MIA-induced OA. © The Korean Society of Food Science and Technology 2019.Entities:
Keywords: Anti-arthritic effect; Highly bioavailable curcumin; Joint; Monosodium iodoacetate; Osteoarthritis
Year: 2019 PMID: 32064134 PMCID: PMC6992805 DOI: 10.1007/s10068-019-00679-5
Source DB: PubMed Journal: Food Sci Biotechnol ISSN: 1226-7708 Impact factor: 2.391